Advertisement

Topics

Sanofi in Talks to Sell Generics Biz for $2.4B

02:24 EDT 17 Apr 2018 | Contract Pharma

Advent International enters into exclusive negotiations to acquire Zentiva, Sanofi's European generics business

Original Article: Sanofi in Talks to Sell Generics Biz for $2.4B

NEXT ARTICLE

More From BioPortfolio on "Sanofi in Talks to Sell Generics Biz for $2.4B"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...